KORY JAMES WENTWORTH

Insider Reports History

Location
Boston, MA
Signature
/s/ Jared Cohen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KORY JAMES WENTWORTH:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. Chief Financial Officer Common Stock 137,987 $1,691,016 $12.25 04 Mar 2026 Direct
Entrada Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 66,600 01 Mar 2026 Direct

Insider Reports Filed by KORY JAMES WENTWORTH

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TRDA Entrada Therapeutics, Inc. 04 Mar 2026 1 -$97,892 4 Chief Financial Officer 06 Mar 2026, 16:36
TRDA Entrada Therapeutics, Inc. 01 Mar 2026 4 -$101,415 4 Chief Financial Officer 03 Mar 2026, 18:20
TRDA Entrada Therapeutics, Inc. 21 Nov 2025 1 -$88,932 4 Chief Financial Officer 24 Nov 2025, 16:30
TRDA Entrada Therapeutics, Inc. 02 Sep 2025 1 -$9,416 4 Chief Financial Officer 04 Sep 2025, 17:02
TRDA Entrada Therapeutics, Inc. 03 Apr 2025 2 +$23,381 4 Chief Financial Officer 04 Apr 2025, 16:34
TRDA Entrada Therapeutics, Inc. 17 Mar 2025 1 -$19,035 4 Chief Financial Officer 19 Mar 2025, 16:32
TRDA Entrada Therapeutics, Inc. 01 Mar 2025 3 -$57,564 4 Chief Financial Officer 04 Mar 2025, 17:00
TRDA Entrada Therapeutics, Inc. 29 Nov 2024 6 -$107,348 4 Chief Financial Officer 03 Dec 2024, 17:26
TRDA Entrada Therapeutics, Inc. 11 Nov 2024 3 -$159,962 4 Chief Financial Officer 13 Nov 2024, 16:47
TRDA Entrada Therapeutics, Inc. 09 Sep 2024 1 -$47,832 4 Chief Financial Officer 10 Sep 2024, 16:34
TRDA Entrada Therapeutics, Inc. 03 Sep 2024 5 -$27,061 4 Chief Financial Officer 05 Sep 2024, 18:46
TRDA Entrada Therapeutics, Inc. 08 Jul 2024 1 -$26,282 4 Chief Financial Officer 10 Jul 2024, 16:34
TRDA Entrada Therapeutics, Inc. 15 Mar 2024 2 +$18,900 4 Chief Financial Officer 19 Mar 2024, 16:33
TRDA Entrada Therapeutics, Inc. 06 Mar 2024 1 -$50,285 4 Chief Financial Officer 08 Mar 2024, 16:36
TRDA Entrada Therapeutics, Inc. 01 Mar 2024 5 -$27,687 4 Chief Financial Officer 05 Mar 2024, 19:47
TRDA Entrada Therapeutics, Inc. 21 Dec 2023 10 -$168,595 4 Chief Financial Officer 26 Dec 2023, 16:35
TRDA Entrada Therapeutics, Inc. 01 Sep 2023 5 -$18,967 4 Chief Financial Officer 06 Sep 2023, 17:11
TRDA Entrada Therapeutics, Inc. 10 Jul 2023 6 -$158,862 4 Chief Financial Officer 12 Jul 2023, 16:34
TRDA Entrada Therapeutics, Inc. 29 Jun 2023 2 +$18,459 4 Chief Financial Officer 30 Jun 2023, 16:32
TRDA Entrada Therapeutics, Inc. 21 Jun 2023 4 -$225,898 4 Chief Financial Officer 23 Jun 2023, 16:20
TRDA Entrada Therapeutics, Inc. 01 Mar 2023 2 $0 4/A Chief Financial Officer 19 Apr 2023, 17:49
TRDA Entrada Therapeutics, Inc. 08 Dec 2022 3 -$76,683 4 Chief Financial Officer 12 Dec 2022, 15:36
TRDA Entrada Therapeutics, Inc. 02 Dec 2022 6 -$50,028 4 Chief Financial Officer 06 Dec 2022, 16:02
TRDA Entrada Therapeutics, Inc. 16 Nov 2022 3 -$3,200 4 Chief Financial Officer 18 Nov 2022, 15:59
TRDA Entrada Therapeutics, Inc. 01 Sep 2022 1 $0 4 Chief Financial Officer 06 Sep 2022, 16:34
TRDA Entrada Therapeutics, Inc. 24 Aug 2022 5 -$62,016 4 Chief Financial Officer 26 Aug 2022, 16:06
TRDA Entrada Therapeutics, Inc. 19 Aug 2022 9 -$139,891 4 Chief Financial Officer 23 Aug 2022, 18:28
TRDA Entrada Therapeutics, Inc. 16 Aug 2022 9 -$7,184 4 Chief Financial Officer 18 Aug 2022, 18:53
TRDA Entrada Therapeutics, Inc. 01 Jul 2022 1 $0 4 Chief Financial Officer 06 Jul 2022, 16:20
TRDA Entrada Therapeutics, Inc. 01 Mar 2022 2 $0 4 Chief Financial Officer 03 Mar 2022, 15:09
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 1 $0 4 Chief Financial Officer 01 Nov 2021, 19:03
TRDA Entrada Therapeutics, Inc. 28 Oct 2021 0 $0 3 Chief Financial Officer 28 Oct 2021, 20:52